Targeted cancer therapy: initial high concentration may slow down selection for resistance
“Unfortunately, any targeted therapy is, always, started with low levels of the drug in the organism, selecting for drug resistance”
2024-08-06
(Press-News.org) BUFFALO, NY- August 6, 2024 – On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new editorial in Volume 16, Issue 14 of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), entitled, “Targeted cancer therapy: the initial high concentration may slow down the selection for resistance.”
“Unfortunately, any targeted therapy is, always, started with low levels of the drug in the organism, selecting for drug resistance. One should propose that initial drug levels must be maximized, and durations may be minimized, ideally, as portions of preemptive combination of targeted drugs.”
Read the full paper: DOI: https://doi.org/10.18632/aging.206046
Corresponding Author: Mikhail V. Blagosklonny - Blagosklonny@oncotarget.com, Blagosklonny@rapalogs.com
Keywords: aging, lung cancer, resistance, brain metastases, METex14, capmatinib, rapamycin
Click here to sign up for free Altmetric alerts about this article.
About Aging-US:
The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.
The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)
Please visit our website at www.Aging-US.com and connect with us:
Facebook
X
Instagram
YouTube
LinkedIn
Reddit
Pinterest
Spotify, or available wherever you listen to podcasts
Click here to subscribe to Aging publication updates.
For media inquiries, please contact media@impactjournals.com.
Aging (Aging-US) Journal Office
6666 E. Quaker Str., Suite 1B
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 1
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-08-06
Mayonnaise continues to help researchers better understand the physics behind nuclear fusion.
“We’re still working on the same problem, which is the structural integrity of fusion capsules used in inertial confinement fusion, and Hellmann’s Real Mayonnaise is still helping us in the search for solutions,” says Arindam Banerjee, the Paul B. Reinhold Professor of Mechanical Engineering and Mechanics at Lehigh University and Chair of the MEM department in the P.C. Rossin College of Engineering and Applied Science.
In simple terms, fusion reactions are what power the sun. If the process could ...
2024-08-06
Minxiang “Glenn” Zeng, an assistant professor in the Department of Chemical Engineering at Texas Tech University, has been awarded a $250,000 grant from the Launching Early-Career Academic Pathways in the Mathematical and Physical Sciences (LEAPS-MPS) award from the National Science Foundation (NSF) to further his research about printable semiconductors and electronics under extreme environments.
The grant supports Zeng’s work in understanding and controlling the thermal degradation pathways of printed metal chalcogenides, which are semiconductor materials including selenides, tellurides and sulfides. His goal is to develop strategies to enhance the thermal stability ...
2024-08-06
The 8th Annual Meeting of the Digital Olfaction Society (DOS) will take place on December 5-6, 2024, in Tokyo, Japan, and Online. The DOS meeting is uniquely aimed at digitizing scents, transferring them, and re-creating them in different parts of the world. The two-day event includes one day dedicated to talks and another day for demonstrations. Under the slogan "Olfaction to Digital Olfaction", the congress will explore the latest advances in olfaction science and digital olfaction technologies, highlighting their transformative impact across multiple fields.
The first day of the congress will focus on olfaction science, scent-based diagnosis and treatment ...
2024-08-06
In 2023, roughly 60,000 firework shells exploded above Manhattan’s East River as part of Macy’s Fourth of July show. The resulting air pollutant levels were many times higher in the hours after the display than those seen when smoke from a Canadian wildfire had blanketed the area a month before.
This is according to the results of a new study, led by researchers at NYU Langone Health, which measured air quality just before and after the Independence Day event, one of the largest in the United States. Tiny particles of hazardous metals and organic compounds peaked at 3,000 micrograms per cubic meter at an air sampling site ...
2024-08-06
A paper out today in Nature Communications reports the discovery of extremely rare early human fossils from the Indonesian island of Flores, including an astonishingly small adult limb bone.
Dated to about 700,000 years old, the new findings shed light on the evolution of Homo floresiensis, the so-called ‘Hobbits’ of Flores whose remains were uncovered in 2003 at Liang Bua cave in the island’s west by a team co-led by Australian-New Zealand archaeologist Professor Mike Morwood (1950–2013).
Archaeological evidence suggests these diminutive, small-brained humans inhabited Liang Bua ...
2024-08-06
About The Study: The results from this study suggest that the higher fracture risk among older women with type 2 diabetes may be due to impaired physical function and not skeletal characteristics.
Corresponding Author: To contact the corresponding author, Mattias Lorentzon, MD, PhD, email mattias.lorentzon@medic.gu.se.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.25106)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...
2024-08-06
About The Study: In this cross-sectional study, the artificial intelligence (AI) model demonstrated strong performance in accurately identifying myopia, strabismus, and ptosis using only smartphone images. These results suggest that such a model could facilitate the early detection of pediatric eye diseases in a convenient manner at home.
Corresponding Authors: To contact the corresponding authors, email Lin Li, MD, PhD (jannetlee130@gmail.com), and Jie Xu, DHM (xujie@pjlab.org.cn).
To access the embargoed ...
2024-08-06
About The Study: This study identifies demographic biases in artificial intelligence (AI)-generated images of physicians with disproportionate representation of white and male physicians and concerning underrepresentation of other races and ethnicities (Asian and Latino) and female physicians in some platforms. This bias has the potential to reinforce stereotypes and undermine diversity, equity, and inclusion initiatives within health care.
Corresponding Author: To contact the corresponding author, Sang Won Lee, MSc, email sangwon_lee@hms.harvard.edu.
To access the embargoed ...
2024-08-06
Leuven, 7 August 2024—The mechanisms underlying intellectual disabilities or autism remain largely unknown. Researchers in the labs of Prof. Pierre Vanderhaeghen and Prof. Vincent Bonin at the VIB-KU Leuven Center for Brain & Disease Research and NERF have discovered that mutations in a gene called SYNGAP1 disrupt the prolonged development of human neurons, which is thought to be essential for normal cognitive function. Their work has interesting implications for our understanding and treatment ...
2024-08-06
**EMBARGOED FOR RELEASE UNTIL AUG. 6 AT 11 A.M. ET**
A protein called Meteorin-like (METRNL) in the tumor microenvironment saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new research directed by investigators at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. Finding ways to block the effects of METRNL signaling on tumor-infiltrating T cells may allow these immune cells to regain the energy necessary to eliminate tumors.
A report about the work was published Aug. 6 in the journal Immunity.
METRNL ...
LAST 30 PRESS RELEASES:
[Press-News.org] Targeted cancer therapy: initial high concentration may slow down selection for resistance
“Unfortunately, any targeted therapy is, always, started with low levels of the drug in the organism, selecting for drug resistance”
